Teva Pharmaceutical Industries earnings were -$1.3B for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest TEVA earnings report on Mar 31, 2025 announced Q1 2025 earnings of $214.0M, down 198.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TEVA reported annual earnings of -$1.6B, with 193.2% growth.
Teva Pharmaceutical Industries Earnings Reports & History FAQ
What were Teva Pharmaceutical Industries's earnings last quarter?
On TEVA's earnings call on Invalid Date, Teva Pharmaceutical Industries (NYSE: TEVA) reported Q1 2025 earnings per share (EPS) of $0.19, up 258.33% year over year. Total TEVA earnings for the quarter were $214.00 million. In the same quarter last year, Teva Pharmaceutical Industries's earnings per share (EPS) was -$0.12.
Is Teva Pharmaceutical Industries profitable or losing money?
As of the last Teva Pharmaceutical Industries earnings report, Teva Pharmaceutical Industries is currently losing money. Teva Pharmaceutical Industries's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$1.29 billion, a 168.48% increase year over year.
What was TEVA's earnings growth in the past year?
As of Teva Pharmaceutical Industries's earnings date in Invalid Date, Teva Pharmaceutical Industries's earnings has grown year over year. TEVA earnings in the past year totalled -$1.29 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.